Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
The Virtual Mentor : VM
|
May 29, 2014
Outside influences on medical practice
Kimberly Swartz
Advances in Skin & Wound Care
|
August 6, 2008
Activated, type I collagen (CellerateRx) and its effectiveness in healing recalcitrant diabetic wounds: a case presentation
Martin I Newman, Larry G Baratta, Kimberly Swartz
The Journal of Clinical Psychiatry
|
May 15, 2026
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial
Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, et al.
JAMA Psychiatry
|
December 6, 2023
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial
Scott T Aaronson, Andrew van der Vaart, Tammy Miller, et al.
The American Journal of Psychiatry
|
January 1, 2025
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial
Scott T Aaronson, Andrew van der Vaart, Tammy Miller, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 3, 2024
A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit
Avery Zierk, Mary Jo Gumbel, Rachel Mackenzie, et al.
Psychiatry Research
|
January 7, 2022
The mental health impact of contact with COVID-19 patients on healthcare workers in the United States
Kelly T Hurst, Elizabeth D Ballard, Grace E Anderson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
The Virtual Mentor : VM
|
May 29, 2014
Outside influences on medical practice
Kimberly Swartz
Advances in Skin & Wound Care
|
August 6, 2008
Activated, type I collagen (CellerateRx) and its effectiveness in healing recalcitrant diabetic wounds: a case presentation
Martin I Newman, Larry G Baratta, Kimberly Swartz
The Journal of Clinical Psychiatry
|
May 15, 2026
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial
Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, et al.
JAMA Psychiatry
|
December 6, 2023
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial
Scott T Aaronson, Andrew van der Vaart, Tammy Miller, et al.
The American Journal of Psychiatry
|
January 1, 2025
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial
Scott T Aaronson, Andrew van der Vaart, Tammy Miller, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 3, 2024
A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit
Avery Zierk, Mary Jo Gumbel, Rachel Mackenzie, et al.
Psychiatry Research
|
January 7, 2022
The mental health impact of contact with COVID-19 patients on healthcare workers in the United States
Kelly T Hurst, Elizabeth D Ballard, Grace E Anderson, et al.
Page
of 1